192 related articles for article (PubMed ID: 17653860)
21. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
Hörl WH; de Alvaro F; Williams PF
Nephrol Dial Transplant; 1999; 14 Suppl 6():10-5. PubMed ID: 10528707
[TBL] [Abstract][Full Text] [Related]
22. Reduction in ESRD reimbursement rate: identifying research priorities and quality indicators.
Parker J
ANNA J; 1990 Apr; 17(2):147-54. PubMed ID: 2183724
[TBL] [Abstract][Full Text] [Related]
23. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management.
Hidai H
Kidney Int; 2000 Jul; 58(1):363-73. PubMed ID: 10886583
[TBL] [Abstract][Full Text] [Related]
24. The organization and funding of the treatment of end-stage renal disease in Australia.
Harris A
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):113-32. PubMed ID: 17763938
[TBL] [Abstract][Full Text] [Related]
25. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
26. [Cost-effectiveness analysis of treatment for end-stage renal disease].
Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
[TBL] [Abstract][Full Text] [Related]
27. Renal Dialysis and its Financing.
Borelli M; Paul DP; Skiba M
Hosp Top; 2016; 94(2):33-8. PubMed ID: 27315562
[TBL] [Abstract][Full Text] [Related]
28. The American health care system. The End Stage Renal Disease Program.
Iglehart JK
N Engl J Med; 1993 Feb; 328(5):366-71. PubMed ID: 8419833
[No Abstract] [Full Text] [Related]
29. Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025.
Sun L; Zou LX; Han YC; Huang HM; Tan ZM; Gao M; Ma KL; Liu H; Liu BC
BMC Nephrol; 2016 Jun; 17(1):60. PubMed ID: 27295981
[TBL] [Abstract][Full Text] [Related]
30. X. The economic cost of ESRD and Medicare spending for alternative modalities of treatment.
Am J Kidney Dis; 1999 Aug; 34(2 Suppl 1):S124-39. PubMed ID: 10431009
[No Abstract] [Full Text] [Related]
31. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
32. Expanding criteria for peritoneal dialysis use.
Palomar R; Arias M
Panminerva Med; 2009 Sep; 51(3):139-50. PubMed ID: 19859049
[TBL] [Abstract][Full Text] [Related]
33. End stage renal disease.
Greer J
Health Care Financ Rev Annu Suppl; 1992; ():199-205. PubMed ID: 10131707
[No Abstract] [Full Text] [Related]
34. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
Teerawattananon Y; Mugford M; Tangcharoensathien V
Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
[TBL] [Abstract][Full Text] [Related]
35. The economic burden of end-stage renal disease in Canada.
Zelmer JL
Kidney Int; 2007 Nov; 72(9):1122-9. PubMed ID: 17700643
[TBL] [Abstract][Full Text] [Related]
36. The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.
Lacson E; Hakim RM
Am J Kidney Dis; 2011 Apr; 57(4):547-9. PubMed ID: 21333423
[No Abstract] [Full Text] [Related]
37. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].
Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H
Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257
[TBL] [Abstract][Full Text] [Related]
38. Policies and health care financing issues for dialysis in Latin America: extracts from the roundtable discussion on the economics of dialysis and chronic kidney disease.
Pecoits-Filho R; Campos C; Cerdas-Calderon M; Fortes P; Jarpa C; Just P; Luconi P; Lugon JR; Pacheco A; Paniagua R; Rodriguez K; Sanabria M; Sciaraffia V; Velasco C; De Arteaga J
Perit Dial Int; 2009 Feb; 29 Suppl 2():S222-6. PubMed ID: 19270223
[TBL] [Abstract][Full Text] [Related]
39. An economic analysis of kidney transplantation.
Evans RW; Kitzmann DJ
Surg Clin North Am; 1998 Feb; 78(1):149-74. PubMed ID: 9531941
[TBL] [Abstract][Full Text] [Related]
40. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance.
Yang WC; Hwang SJ;
Nephrol Dial Transplant; 2008 Dec; 23(12):3977-82. PubMed ID: 18628366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
